Emerging Growth Research Releases Q1:26 Quarterly Update on SBC Medical Group; Upgrades to Buy Rating and Increases Price Target to $10.00
Go back to Emerging Growth Research Releases Q1:26 Quarterly Update on SBC Medical Group; Upgrades to Buy Rating and Increases Price Target to $10.00| US BioTec Inc New Common Shares (NASDAQ: SBC) | Delayed: 3.07 +0.07 (2.33%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.00 | 52 Week High | $0.40 | |||
| Open | $3.05 | 52 Week Low | $0.40 | |||
| Day High | $3.07 | P/E | N/A | |||
| Day Low | $3.00 | EPS | $0.00 | |||
| Volume | 78,167 | |||||
